Log in to save to my catalogue

International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medic...

International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2654287628

International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines

About this item

Full title

International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines

Publisher

Cham: Springer International Publishing

Journal title

The AAPS journal, 2022-04, Vol.24 (3), p.56-56, Article 56

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Recalls of some batches of metformin have occurred due to the detection of
N
-nitrosodimethylamine (NDMA) in amounts above the acceptable intake (AI) of 96 ng per day. Prior to the recalls, an international regulatory laboratory network had been monitoring drugs for nitrosamine impurities with each laboratory independently developing and vali...

Alternative Titles

Full title

International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2654287628

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2654287628

Other Identifiers

ISSN

1550-7416

E-ISSN

1550-7416

DOI

10.1208/s12248-022-00702-4

How to access this item